Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small cell lung cancer Read more
Alembic Pharma announces US FDA final approval for Arformoterol Tartrate Inhalation Solution Read more
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine Read more